Literature DB >> 28822332

ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3).

Shani Paluch-Shimon1, Olivia Pagani2, Ann H Partridge3, Omalkhair Abulkhair4, Maria-João Cardoso5, Rebecca Alexandra Dent6, Karen Gelmon7, Oreste Gentilini8, Nadia Harbeck9, Anita Margulies10, Dror Meirow1, Giancarlo Pruneri11, Elzbieta Senkus12, Tanja Spanic13, Medha Sutliff14, Luzia Travado5, Fedro Peccatori15, Fatima Cardoso16.   

Abstract

The 3rd International Consensus Conference for Breast Cancer in Young Women (BCY3) took place in November 2016, in Lugano, Switzerland organized by the European School of Oncology (ESO) and the European Society of Medical Oncologists (ESMO). Consensus recommendations for the management of breast cancer in young women were updated from BCY2 with incorporation of new evidence to inform the guidelines, and areas of research priorities were identified. This manuscript summarizes the ESO-ESMO international consensus recommendations, which are also endorsed by the European Society of Breast Specialists (EUSOMA).
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Guidelines

Mesh：

Year:  2017        PMID： 28822332     DOI： 10.1016/j.breast.2017.07.017

Source DB:  PubMed          Journal:  Breast        ISSN： 0960-9776            Impact factor:   4.380


  67 in total

1.  ABC4 Consensus: Assessment by a German Group of Experts.

Authors:  Nadia Harbeck; Diana Lüftner; Norbert Marschner; Michael Untch; Doris Augustin; Susanne Briest; Johannes Ettl; Renate Haidinger; Lothar Müller; Volkmar Müller; Eugen Ruckhäberle; Rachel Wuerstlein; Christoph Thomssen
Journal:  Breast Care (Basel)       Date:  2018-02-15       Impact factor: 2.860

2.  Adjuvant Systemic Treatment of Premenopausal Women With Hormone Receptor-Positive Early Breast Cancer: Lights and Shadows.

Authors:  Meredith M Regan; Gini F Fleming; Barbara Walley; Prudence A Francis; Olivia Pagani
Journal:  J Clin Oncol       Date:  2019-02-27       Impact factor: 44.544

3.  The implementation of a commercially available multi-gene profile test for breast cancer characterization in a department of pathology: what have we learned from the first 100 cases?

Authors:  Cristina Pelliccia; Emanuele Caselli; Martina Mandarano; Rachele Del Sordo; Guido Bellezza; Angelo Sidoni
Journal:  Virchows Arch       Date:  2021-01-06       Impact factor: 4.064

Review 4.  Triptorelin: A Review of its Use as an Adjuvant Anticancer Therapy in Early Breast Cancer.

Authors:  James E Frampton
Journal:  Drugs       Date:  2017-12       Impact factor: 9.546

5.  Differences in Breast Cancer Stage at Diagnosis by Ethnicity, Insurance Status, and Family Income in Young Women in the USA.

Authors:  Maria Alice Franzoi; Gilberto Schwartsmann; Sérgio Jobim de Azevedo; Guilherme Geib; Facundo Zaffaroni; Pedro E R Liedke
Journal:  J Racial Ethn Health Disparities       Date:  2019-05-17

6.  Adjuvant Anti-HER2 Therapy, Treatment-Related Amenorrhea, and Survival in Premenopausal HER2-Positive Early Breast Cancer Patients.

Authors:  Matteo Lambertini; Christine Campbell; José Bines; Larissa A Korde; Miguel Izquierdo; Debora Fumagalli; Lucia Del Mastro; Michail Ignatiadis; Kathleen Pritchard; Antonio C Wolff; Christian Jackisch; Istvan Lang; Michael Untch; Ian Smith; Frances Boyle; Binghe Xu; Carlos H Barrios; José Baselga; Alvaro Moreno-Aspitia; Martine Piccart; Richard D Gelber; Evandro de Azambuja
Journal:  J Natl Cancer Inst       Date:  2019-01-01       Impact factor: 13.506

7.  Genetic predictors of chemotherapy-related amenorrhea in women with breast cancer.

Authors:  Kathryn J Ruddy; Daniel J Schaid; Ann H Partridge; Nicholas B Larson; Anthony Batzler; Lothar Häberle; Ralf Dittrich; Peter Widschwendter; Visnja Fink; Emanuel Bauer; Judith Schwitulla; Matthias Rübner; Arif B Ekici; Viktoria Aivazova-Fuchs; Elizabeth A Stewart; Matthias W Beckmann; Elizabeth Ginsburg; Liewei Wang; Richard M Weinshilboum; Fergus J Couch; Wolfgang Janni; Brigitte Rack; Celine Vachon; Peter A Fasching
Journal:  Fertil Steril       Date:  2019-07-29       Impact factor: 7.329

8.  Young Women with Breast Cancer: Fertility Preservation Options and Management of Pregnancy-Associated Breast Cancer.

Authors:  Nikita M Shah; Dana M Scott; Pridvi Kandagatla; Molly B Moravek; Erin F Cobain; Monika L Burness; Jacqueline S Jeruss
Journal:  Ann Surg Oncol       Date:  2019-01-24       Impact factor: 5.344

Review 9.  Tamoxifen Exposure during Pregnancy: A Systematic Review and Three More Cases.

Authors:  Barbara Buonomo; Antonella Brunello; Stefania Noli; Loredana Miglietta; Lucia Del Mastro; Matteo Lambertini; Fedro Alessandro Peccatori
Journal:  Breast Care (Basel)       Date:  2019-07-25       Impact factor: 2.860

10.  Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.

Authors:  Prudence A Francis; Olivia Pagani; Gini F Fleming; Barbara A Walley; Marco Colleoni; István Láng; Henry L Gómez; Carlo Tondini; Eva Ciruelos; Harold J Burstein; Hervé R Bonnefoi; Meritxell Bellet; Silvana Martino; Charles E Geyer; Matthew P Goetz; Vered Stearns; Graziella Pinotti; Fabio Puglisi; Simon Spazzapan; Miguel A Climent; Lorenzo Pavesi; Thomas Ruhstaller; Nancy E Davidson; Robert Coleman; Marc Debled; Stefan Buchholz; James N Ingle; Eric P Winer; Rudolf Maibach; Manuela Rabaglio-Poretti; Barbara Ruepp; Angelo Di Leo; Alan S Coates; Richard D Gelber; Aron Goldhirsch; Meredith M Regan
Journal:  N Engl J Med       Date:  2018-06-04       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.